• Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Dividend Stocks Report
No Result
View All Result
Home Stock News

Omicron Covid variant poses greater risk for the unvaccinated, former White House advisor says

by
December 6, 2021
in Stock News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Jim Rogers warns of the ‘worst bear market’ in his lifetime – these are the 2 ‘least dangerous’ assets to own today

GM Stock Has Been Hammered, Which Makes Owning a Piece of Its EV Future a Bargain

Russian shelling hits chemical plant where civilians are trapped, says Ukraine

‘I’m outraged:’ Women react to Roe v. Wade ruling outside of Supreme Court

STR | NurPhoto | Getty Images

The new omicron Covid variant poses a greater risk for the unvaccinated and there’s reason to believe that current vaccines are going to be “quite effective,” a former White House advisor said Monday.

“What we know for sure is that it is a dangerous variant for people who have not been vaccinated,” Andy Slavitt told CNBC’s “Squawk Box Asia.”

“What we have to get to learn is whether or not omicron — how it spreads in an environment where delta is strong,” he said.

Slavitt previously served as a senior advisor on President Joe Biden’s coronavirus response team and ran the Centers for Medicare & Medicaid Services under the Obama administration.

The omicron strain was first identified by South African scientists and it has been detected in several countries including the United States, the United Kingdom, Australia and Germany.

Health experts are concerned about the omicron variant’s transmissibility given its unusual constellation of mutations and profile that differs from previous variants of concern. Scientists are also trying to figure out how effective current vaccines are in protecting people against any severe illness due to the new strain.

“I think we have good reason to believe that the vaccines are effective, if not as effective, and that with boosters, they’ll be quite effective,” Slavitt told CNBC. “But pharma’s also going back to the drawing board.”

Covid vaccine makers Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca said they are investigating and testing the omicron variant.

Slavitt said it is possible that there would be updated vaccines available, if needed, in the next several months, before the omicron variant starts to spread meaningfully.

But the main problem that the world currently faces is vaccine inequity. Information compiled by Our World In Data showed just around 44% of the world population has been fully vaccinated against Covid-19. But only a small percentage of people in low-income countries have received at least one dose.

Slavitt explained that it is still too early to tell how omicron will fare compared with the lethal delta strain.

“We get to a point when we have a variant that replaces delta that is not serious or can be easily treated with medication, then that’ll be a very new day for this pandemic. We can knock on wood that happens now, if it’s not with omicron, it’ll may be the next one,” he said, adding that such a scenario could potentially turn Covid more akin to the common cold.

Next Post

European stocks head for higher open as omicron variant, bitcoin volatility watched

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Stock News

Jim Rogers warns of the ‘worst bear market’ in his lifetime – these are the 2 ‘least dangerous’ assets to own today

by
June 25, 2022
0

Bloomberg Brace for the Most Expensive, Manic Minutes of the Trading Year (Bloomberg) -- In 1991, Nobel laureate William Sharpe...

Read more

Jim Rogers warns of the ‘worst bear market’ in his lifetime – these are the 2 ‘least dangerous’ assets to own today

GM Stock Has Been Hammered, Which Makes Owning a Piece of Its EV Future a Bargain

‘I’m outraged:’ Women react to Roe v. Wade ruling outside of Supreme Court

Russian shelling hits chemical plant where civilians are trapped, says Ukraine

El Salvador’s $425 million bitcoin experiment isn’t saving the country’s finances

Schedule for Week of June 26, 2022

Load More

All rights reserved by www.dividendstocksreport.net

  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.